Cargando…

Fatty acids and recurrence of major depressive disorder: combined analysis of two Dutch clinical cohorts

OBJECTIVE: Omega‐3 (n‐3) and omega‐6 (n‐6) polyunsaturated fatty acid (PUFA) alterations in patients with major depressive disorder (MDD) have been shown to persist after remission. Whether these alterations are risk factors for MDD recurrence remains unknown. Here, we examined whether fatty acids p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thesing, C. S., Lok, A., Milaneschi, Y., Assies, J., Bockting, C. L. H., Figueroa, C. A., Giltay, E. J., Penninx, B. W. J. H., Ruhé, H. G., Schene, A. H., Bot, M., Mocking, R. J. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7216896/ https://www.ncbi.nlm.nih.gov/pubmed/31785112 http://dx.doi.org/10.1111/acps.13136

Ejemplares similares

Ala54Thr Fatty Acid-Binding Protein 2 (FABP2) Polymorphism in Recurrent Depression: Associations with Fatty Acid Concentrations and Waist Circumference
por: Mocking, Roel J. T., et al.
Publicado: (2013)

Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder
por: Mocking, R J T, et al.
Publicado: (2016)

Effects of oxidative stress on fatty acid- and one-carbon-metabolism in psychiatric and cardiovascular disease comorbidity
por: Assies, J, et al.
Publicado: (2014)

Statistical Methodological Issues in Handling of Fatty Acid Data: Percentage or Concentration, Imputation and Indices
por: Mocking, Roel J. T., et al.
Publicado: (2012)

Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence
por: Mocking, Roel J. T., et al.
Publicado: (2021)

Plasma and Erythrocyte Fatty Acid Patterns in Patients with Recurrent Depression: A Matched Case-Control Study
por: Assies, Johanna, et al.
Publicado: (2010)

Correction to: Metabolic features of recurrent major depressive disorder in remission, and the risk of future recurrence
por: Mocking, Roel J. T., et al.
Publicado: (2021)

Vulnerability for new episodes in recurrent major depressive disorder: protocol for the longitudinal DELTA-neuroimaging cohort study
por: Mocking, Roel J T, et al.
Publicado: (2016)

Interaction between the MTHFR C677T polymorphism and traumatic childhood events predicts depression
por: Lok, A, et al.
Publicado: (2013)

The measurement of cognitive reactivity to sad mood in patients remitted from major depressive disorder
por: Figueroa, Caroline A., et al.
Publicado: (2018)

Biological Effects of Add-On Eicosapentaenoic Acid Supplementation in Diabetes Mellitus and Co-Morbid Depression: A Randomized Controlled Trial
por: Mocking, Roel J. T., et al.
Publicado: (2012)

Emotional Biases and Recurrence in Major Depressive Disorder. Results of 2.5 Years Follow-Up of Drug-Free Cohort Vulnerable for Recurrence
por: Ruhe, Henricus G., et al.
Publicado: (2019)

Impaired reward-related learning signals in remitted unmedicated patients with recurrent depression
por: Geugies, Hanneke, et al.
Publicado: (2019)

Aberrant default-mode network-hippocampus connectivity after sad memory-recall in remitted-depression
por: Figueroa, Caroline A, et al.
Publicado: (2017)

Metabolomic profiles discriminating anxiety from depression
por: de Kluiver, Hilde, et al.
Publicado: (2021)

Altered ability to access a clinically relevant control network in patients remitted from major depressive disorder
por: Figueroa, Caroline A., et al.
Publicado: (2019)

Depression recurrence is accompanied by longer periods in default mode and more frequent attentional and reward processing dynamic brain‐states during resting‐state activity
por: Alonso, Sonsoles, et al.
Publicado: (2023)

Supplementation‐induced increase in circulating omega‐3 serum levels is not associated with a reduction in depressive symptoms: Results from the MooDFOOD depression prevention trial
por: Thesing, Carisha S., et al.
Publicado: (2020)

A role for vitamin D and omega-3 fatty acids in major depression? An exploration using genomics
por: Milaneschi, Yuri, et al.
Publicado: (2019)

Metabolomics signatures of depression: the role of symptom profiles
por: de Kluiver, Hilde, et al.
Publicado: (2023)

Association of food groups with depression and anxiety disorders
por: Gibson-Smith, Deborah, et al.
Publicado: (2019)

Pathophysiology of major depressive disorder: mechanisms involved in etiology are not associated with clinical progression
por: Verduijn, J, et al.
Publicado: (2015)

Heterogeneity in depressive and anxiety symptoms and loneliness during the COVID-19 pandemic: Results from three Dutch psychiatric case-control cohorts from April 2020 to February 2022
por: Klokgieters, Silvia S., et al.
Publicado: (2023)

Can a One-Item Mood Scale Do the Trick? Predicting Relapse over 5.5-Years in Recurrent Depression
por: van Rijsbergen, Gerard D., et al.
Publicado: (2012)

Resequencing Three Candidate Genes for Major Depressive Disorder in a Dutch Cohort
por: Verbeek, Eva C., et al.
Publicado: (2013)

Major Depressive Disorder and Lifestyle: Correlated Genetic Effects in Extended Twin Pedigrees
por: Huider, Floris, et al.
Publicado: (2021)

The similarity of the structure of DSM-IV criteria for major depression in depressed women from China, the United States and Europe
por: Kendler, K. S., et al.
Publicado: (2015)

Major depression and enhanced molecular senescence abnormalities in young and middle-aged adults
por: Diniz, Breno S., et al.
Publicado: (2019)

Sex Differences in Serum Markers of Major Depressive Disorder in the Netherlands Study of Depression and Anxiety (NESDA)
por: Ramsey, Jordan M., et al.
Publicado: (2016)

The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts
por: Pan, Kuan-Yu, et al.
Publicado: (2021)

Reconsidering the prognosis of major depressive disorder across diagnostic boundaries: full recovery is the exception rather than the rule
por: Verduijn, Judith, et al.
Publicado: (2017)

Serum proteomic profiling of major depressive disorder
por: Bot, M, et al.
Publicado: (2015)

Effectiveness of Emotional Memory Reactivation vs Control Memory Reactivation Before Electroconvulsive Therapy in Adult Patients With Depressive Disorder: A Randomized Clinical Trial
por: Scheepens, Dominique S., et al.
Publicado: (2020)

Anxious or Depressed and Still Happy?
por: Spinhoven, Philip, et al.
Publicado: (2015)

Severity, course trajectory, and within‐person variability of individual symptoms in patients with major depressive disorder
por: van Eeden, W. A., et al.
Publicado: (2018)

The impact of COVID-19-pandemic-related adversity on mental health: longitudinal study in Dutch populations with and without mental health disorders
por: Maran, Patricia Laura, et al.
Publicado: (2023)

Involvement of inflammatory gene expression pathways in depressed patients with hyperphagia
por: de Kluiver, Hilde, et al.
Publicado: (2019)

BIDIRECTIONAL PROSPECTIVE ASSOCIATIONS OF METABOLIC SYNDROME COMPONENTS WITH DEPRESSION, ANXIETY, AND ANTIDEPRESSANT USE
por: Hiles, Sarah A., et al.
Publicado: (2016)

Attitudes towards COVID‐19 vaccination: A comparison between persons with different chronicity of pre‐pandemic depressive, anxiety or obsessive–compulsive disorders
por: Pan, Kuan‐Yu, et al.
Publicado: (2022)

Dissection of depression heterogeneity using proteomic clusters
por: van Haeringen, Marije, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_96cq1pe24qm3q3lj4222l4flsg